Skip to main navigation
Skip to search
Skip to main content
Utrecht University Home
Help & FAQ
Home
People
Research units
Research output
Activities
In the media
Prizes & Grants
Search by expertise, name or affiliation
Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users
Talitha I Verhoef
, W Ken Redekop
,
Marcel L Bouvy
, Brenda Dorenbos
, Zamiera Karwar
, Rianne M F van Schie
,
Anthonius de Boer
, Anke-Hilse Maitland-van der Zee
*
, EU-PACT Group
*
Corresponding author for this work
Dept of Pharmaceutical Sciences
Pharmacoepidemiology and Clinical Pharmacology
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Dutch
100%
Coumarin
100%
Phenprocoumon
100%
Acenocoumarol
100%
Beliefs about Medicines
100%
Cardiovascular Drugs
66%
Venous Thromboembolism
50%
Atrial Fibrillation
50%
New User
33%
Antihypertensive Drugs
16%
AIMS™
16%
Statins
16%
International Normalized Ratio
16%
Positive Attitude
16%
Drug Users
16%
Coumarin Derivatives
16%
Therapy Adherence
16%
Patient Beliefs
16%
Beliefs about Medicines Questionnaire
16%
Medication Beliefs
16%
User Score
16%
Pharmacology, Toxicology and Pharmaceutical Science
Coumarin Derivative
100%
Acenocoumarol
100%
Phenprocoumon
100%
Cardiovascular Agent
66%
Venous Thromboembolism
50%
Atrial Fibrillation
50%
Coumarin
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Antihypertensive Drug
16%